Please login to the form below

Not currently logged in
Email:
Password:

Kane and Finkel

This page shows the latest Kane and Finkel news and features for those working in and with pharma, biotech and healthcare.

Kane & Finkel closes

Kane & Finkel closes

The partnership between the two principals, Finkel and managing director John Kane, has been dissolved, and the two will no long work together. ... Merck. Kane &Finkel served clients across the US, Asia and Europe. At one point, the agency had 75 staff,

Latest news

  • Can science be branded and sold? Can science be branded and sold?

    It must be packaged into a form that's accessible, compelling and distinctive. ... client services director, Europe at Kane &Finkel Healthcare Communications and can be reached at dknechtel@kaneandfinkel.com.

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Kane & Finkel announces new European director

    Commenting on his appointment, Flaherty said: “I am looking forward to the exciting developments Kane &Finkel has in progress and to bringing the expertise of a highly creative independent agency to ... John Kane, principal and managing director of

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics